CXCR3 and breast carcinoma: For instance, we have recently found that these CXCR3 ligands influence the emergence of metastatic breast cancer cells from dormancy in the liver MPS (Clark et al., 2016; manuscript in preparation), demonstrating a novel gut‐liver crosstalk cause of the previously noted effect of inflammatory chemokines in metastatic breast cancer (Kitamura and Pollard, 2015).